A detailed history of Advisory Resource Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisory Resource Group holds 1,887 shares of ABBV stock, worth $384,098. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,887
Previous 1,975 4.46%
Holding current value
$384,098
Previous $359,000 10.03%
% of portfolio
0.08%
Previous 0.09%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $13,621 - $15,906
-88 Reduced 4.46%
1,887 $323,000
Q1 2024

May 17, 2024

BUY
$159.82 - $182.1 $1,758 - $2,003
11 Added 0.56%
1,975 $359,000
Q4 2023

Jan 11, 2024

BUY
$137.6 - $154.97 $1,926 - $2,169
14 Added 0.72%
1,964 $304,000
Q3 2023

Dec 05, 2023

SELL
$133.59 - $154.65 $29,790 - $34,486
-223 Reduced 10.26%
1,950 $290,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $32,199 - $40,070
-243 Reduced 10.06%
2,173 $292,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $7,085 - $8,160
49 Added 2.07%
2,416 $385,000
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $1,521 - $1,824
11 Added 0.47%
2,367 $0
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $1,610 - $1,847
12 Added 0.51%
2,356 $316,000
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $1,513 - $1,924
11 Added 0.47%
2,344 $359,000
Q1 2022

Apr 06, 2022

BUY
$131.98 - $163.75 $1,451 - $1,801
11 Added 0.47%
2,333 $378,000
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $3,974 - $5,029
-37 Reduced 1.57%
2,322 $318,000
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $1,064 - $1,207
10 Added 0.43%
2,359 $254,000
Q2 2021

Aug 19, 2021

BUY
$105.21 - $117.21 $1,157 - $1,289
11 Added 0.47%
2,349 $265,000
Q1 2021

May 24, 2021

BUY
$102.3 - $112.62 $1,125 - $1,238
11 Added 0.47%
2,338 $253,000
Q4 2020

Feb 23, 2021

BUY
$80.49 - $108.67 $885 - $1,195
11 Added 0.47%
2,327 $249,000
Q3 2020

Dec 09, 2020

BUY
$85.91 - $100.83 $2,920 - $3,428
34 Added 1.49%
2,316 $203,000
Q2 2020

Aug 19, 2020

BUY
$73.37 - $98.18 $167,430 - $224,046
2,282 New
2,282 $224,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisory Resource Group Portfolio

Follow Advisory Resource Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.